TY - JOUR
T1 - De novo and biallelic DEAF1 variants cause a phenotypic spectrum
AU - Nabais Sá, Maria J.
AU - Jensik, Philip J.
AU - McGee, Stacey R.
AU - Parker, Michael J.
AU - Lahiri, Nayana
AU - McNeil, Evan P.
AU - Kroes, Hester Y.
AU - Hagerman, Randi J.
AU - Harrison, Rachel E.
AU - Montgomery, Tara
AU - Splitt, Miranda
AU - Palmer, Elizabeth E.
AU - Sachdev, Rani K.
AU - Mefford, Heather C.
AU - Scott, Abbey A.
AU - Martinez-Agosto, Julian A.
AU - Lorenz, Rüdiger
AU - Orenstein, Naama
AU - Berg, Jonathan N.
AU - Amiel, Jeanne
AU - Heron, Delphine
AU - Keren, Boris
AU - Cobben, Jan-Maarten
AU - Menke, Leonie A.
AU - Marco, Elysa J.
AU - Graham, John M.
AU - Pierson, Tyler Mark
AU - Karimiani, Ehsan Ghayoor
AU - Maroofian, Reza
AU - Manzini, M. Chiara
AU - Cauley, Edmund S.
AU - Colombo, Roberto
AU - Odent, Sylvie
AU - Dubourg, Christele
AU - Phornphutkul, Chanika
AU - de Brouwer, Arjan P. M.
AU - de Vries, Bert B. A.
AU - Vulto-vanSilfhout, Anneke T
N1 - This work was financially supported by grants from the Dutch Organization for Health Research and Development (ZON-MW grants 917–86–319 and 912–12–109 to B.B.A.d.V.), the Cedars-Sinai Diana and Steve Marienhoff Fashion Industries Guild Endowed Fellowship in Pediatric Neuromuscular Diseases (to T.M.P.), the March of Dimes (grant 6-FY14–422 to M.C.M.), and the National Institutes of Health (grants NINDS 5R21NS091724 to P.J.J. and NINDS R01NS069605 to H.C.M.).
PY - 2019/9
Y1 - 2019/9
N2 - Purpose: To investigate the effect of different DEAF1 variants on the phenotype of patients with autosomal dominant and recessive inheritance patterns and on DEAF1 activity in vitro.Methods: We assembled a cohort of 23 patients with de novo and biallelic DEAF1 variants, described the genotype-phenotype correlation, and investigated the differential effect of de novo and recessive variants on transcription assays using DEAF1 and Eif4g3 promoter luciferase constructs.Results: The proportion of the most prevalent phenotypic features, including intellectual disability, speech delay, motor delay, autism, sleep disturbances, and a high pain threshold, were not significantly different in patients with biallelic and pathogenic de novo DEAF1 variants. However, microcephaly was exclusively observed in patients with recessive variants (p < 0.0001).Conclusion: We propose that different variants in the DEAF1 gene result in a phenotypic spectrum centered around neurodevelopmental delay. While a pathogenic de novo dominant variant would also incapacitate the product of the wild-type allele and result in a dominant-negative effect, a combination of two recessive variants would result in a partial loss of function. Because the clinical picture can be nonspecific, detailed phenotype information, segregation, and functional analysis are fundamental to determine the pathogenicity of novel variants and to improve the care of these patients.
AB - Purpose: To investigate the effect of different DEAF1 variants on the phenotype of patients with autosomal dominant and recessive inheritance patterns and on DEAF1 activity in vitro.Methods: We assembled a cohort of 23 patients with de novo and biallelic DEAF1 variants, described the genotype-phenotype correlation, and investigated the differential effect of de novo and recessive variants on transcription assays using DEAF1 and Eif4g3 promoter luciferase constructs.Results: The proportion of the most prevalent phenotypic features, including intellectual disability, speech delay, motor delay, autism, sleep disturbances, and a high pain threshold, were not significantly different in patients with biallelic and pathogenic de novo DEAF1 variants. However, microcephaly was exclusively observed in patients with recessive variants (p < 0.0001).Conclusion: We propose that different variants in the DEAF1 gene result in a phenotypic spectrum centered around neurodevelopmental delay. While a pathogenic de novo dominant variant would also incapacitate the product of the wild-type allele and result in a dominant-negative effect, a combination of two recessive variants would result in a partial loss of function. Because the clinical picture can be nonspecific, detailed phenotype information, segregation, and functional analysis are fundamental to determine the pathogenicity of novel variants and to improve the care of these patients.
KW - DEAF1
KW - genotype
KW - intellectual disability
KW - neurodevelopmental disorder
KW - phenotype
UR - http://www.scopus.com/inward/record.url?scp=85063615212&partnerID=8YFLogxK
U2 - 10.1038/s41436-019-0473-6
DO - 10.1038/s41436-019-0473-6
M3 - Article
C2 - 30923367
SN - 1098-3600
VL - 21
SP - 2059
EP - 2069
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 9
ER -